Frontotemporal dementia: Treatment response to serotonin selective reuptake inhibitors

Journal of Clinical Psychiatry

Volumn 58, Issue 5, 1997, Pages 212-216

  Swartz, J Randolph ^a,b   Miller, Bruce L ^a,b   Lesser, Ira M ^a,b   Darby, Amy L ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CLOMIPRAMINE; CYPROHEPTADINE; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE;

ADULT; AGED; AGITATION; ALZHEIMER DISEASE; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DIARRHEA; FEMALE; FOOD PREFERENCE; FRONTAL LOBE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; TEMPORAL LOBE;

EID: 0030947255     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v58n0506     Document Type: Article

References (53)

1. Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57:416-418
2. Pick A. Uber die Beziehungen der senile Hirnatrophie zur Aphasie. Pragmatische Medizinische Wehnschrift 1892;17:165-167
3. Ferraro A, Jervis GA. Pick's disease: clinicopathologic study and report of two cases. Archives of Neurology and Psychiatry 1936;36:739-767
4. Sjogren T, Sjogren H, Lindgren AGH. Morbus Alzheimer and morbus Pick: a genetic, clinical, and patho-anatomical study. Acta Psychiatr Neurol Scand 1952;(suppl 82)
5. Cummings JL, Benson DF. Dementia: A Clinical Approach. 2nd ed. Stoneham, Mass: Butterworth-Heinemann; 1992
6. Gans A. Betrachtungen uber art und ausbreitung des krankhaften prozesses in einem fall von Pickscher atrophic des stirnhirns. Zeitschrift fur die Gesamte Neurologie und Psychiatrie 1922;80:10-28
7. Kahn E, Thompson LJ. Concerning Pick's disease. Am J Psychiatry 1933; 90:937-946
8. Gustafson L. Frontal lobe degeneration of non-Alzheimer type, II: clinical picture and differential diagnosis. Archives of Gerontology and Geriatrics 1987;6:209-223
9. Neary D, Snowden JS, Northen B, et al. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 1988;51:353-361
10. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991;41:1374-1382
11. Gustafson L. Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia 1993;4:143-148
12. Barber R, Snowden JS, Craufurd D. Frontotemporal dementia and Alzheimer's disease: retrospective differentiation using information from informants. J Neurol Neurosurg Psychiatry 1995;59:61-70
13. Cummings JL, Duchen LW. Klüver-Bucy Syndrome in Pick disease: clinical and pathological correlations. Neurology 1981;31:1415-1422
14. Klüver H, Bucy PC. Preliminary analysis of functions of the temporal lobes in monkeys. Archives of Neurology and Psychiatry 1939;42: 547-554
15. Miller BL, Darby AL, Swartz JR, et al. Dietary changes, compulsions, and sexual behavior in frontotemporal degeneration. Dementia 1995;6: 195-199
16. Gonzalez MP, Lopez OL, Sudilovsky A, et al. Differences in neuropsychiatric profile in Alzheimer's disease and non-Alzheimer's disease dementias. In: New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association; May 22, 1995; Miami, Fla. Abstract NR31:61-62
17. Anderson IM, Scott K, Harborne G. Serotonin and depression in frontal lobe dementia [letter]. Am J Psychiatry 1995;152:645
18. Tonkonogy JM, Smith TW, Barreira PJ. Obsessive-compulsive disorders in Pick's disease. J Neuropsychiatry Clin Neurosci 1994;6:176-180
19. Mendez MF, Selwood A, Mastri AF, et al. Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology 1993; 43:289-292
20. Read S, Miller BL, Mena I, et al. SPECT/pathology correlations in dementia. J Am Geriatr Soc 1995;43:1243-1247
21. Risberg J, Passant U, Warkentin S, et al. Regional cerebral blood flow in frontal lobe dementia of the non-Alzheimer type. Dementia 1993;14: 186-187
22. Montgomery SA, Fineberg N. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses? Br J Psychiatry 1989;155(8, suppl):63-70
23. Leonard BE. Serotonin receptors: where are they going? Int Clin Psychopharmacol 1994;9(1, suppl):7-17
24. Dubovsky SL, Thomas M. Serotonergic mechanisms and current and future psychiatric practice. J Clin Psychiatry 1995;56(suppl 2):38-48
25. Sparks DL, Markesbery WR. Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch Neurol 1991;48:796-799
26. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:185-198
27. Boone KB, Miller BL, Lesser IM, et al. Performance on frontal lobe tests in healthy, older individuals. Developmental Neuropsychology 1990;6: 215-223
28. Boone KB, Lesser IM, Miller BL, et al. Cognitive functioning in older depressed outpatients: relationship of presence and severity of depression to neuropsychological test scores. Neuropsychology 1995;9:390-398
29. Elfgren C, Passant U, Risberg J. Neuropsychological findings in frontal lobe dementia. Dementia 1993;4:214-219
30. Clinical Global Impressions. Guy W, ed. ECDEU Assessment Manual for Psychopharmacology, Revised. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:217-222
31. Brown GL, Ebert MH, Goyer PF, et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 1982;139: 741-746
32. Lidberg L, Tuck JR, Asberg M, et al. Homicide, suicide and CSF 5HIAA. Acta Psychiatr Scand 1985;71:230-236
33. Roy A, Linnoila M. Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr Scand 1988;78:529-535
34. Coccaro EF, Siever LJ, Klar H, et al. Serotonergic studies in patients with affective and personality disorders: correlates with behavioral aggression and impulsivity. Arch Gen Psychiatry 1989;46:587-596
35. Kelley LA, Hellings JA, Gabrielli WF, et al. Sertraline response in mentally retarded adults. In: New Research Program and Abstracts of the 146th Annual Meeting of the American Psychiatric Association; May 24, 1993; San Francisco, Calif. Abstract NR173:103
36. Campbell JJ III, Duffy JD. Sertraline treatment of aggression in a developmentally disabled patient [letter]. J Clin Psychiatry 1995;56:123-124
37. de Koning P, Mak M, de Vries MH, et al. Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo-and baseline-controlled multi-centre study. Int Clin Psychopharmacol 1994;9:187-194
38. Ratey JJ, Sovner R, Mikkelsen E, et al. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. J Clin Psychiatry 1989;50:382-384
39. Sakauye KM, Camp CJ, Ford PA. Effects of buspirone on agitation associated with dementia. Am J Geriatr Psychiatry 1993;1:82-84
40. Craft M, Ismael IA, Krishnamurti D, et al. Lithium in the treatment of aggression in mentally handicapped patients. Br J Psychiatry 1987;150: 685-689
41. Wickham EA, Reed JV. Lithium for the control of aggressive and self-mutilating behaviour. Int Clin Psychopharmacol 1987;2:181-190
42. Wood AJ, Goodwin GM. A review of the biochemical and neuropharmacological actions of lithium. Psychol Med 1987;17:579-600
43. Healy D, Carney PA, Leonard BE. Monoamine-related markers of depression: changes following treatment. J Psychiatr Res 1983;17:251-260
44. Butler J, Tannian M, Leonard BE. The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomized rats. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12:585-594
45. Leibowitz SF. Neurochemical systems of the hypothalamus in control of feeding and drinking behavior and water and electrolyte excretion. In: Morgane P, Panksepp J, eds. Handbook of the Hypothalamus, vol 3. New York, NY: Decker; 1980:299-437
46. Morley JE, Levine AS. The pharmacology of eating behavior. Annu Rev Pharmacol Toxicol 1985;25:127-146
47. Garattini S, Mennini T, Samanin R. Reduction of food intake by manipulation of central serotonin: current experimental results. Br J Psychiatry 1989;155(8, suppl):41-51
48. Garattini S, Bizzi A, Codegoni AM, et al. Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am J Clin Nutr 1992;55(1, suppl):160S-166S
49. Kasper S, Fuger J, Moller HJ. Comparative efficacy of antidepressants. Drugs 1992;43(2, suppl):11-23
50. Yager J. The treatment of eating disorders. J Clin Psychiatry 1988;49(9, suppl):18-25
51. Halmi K, Eckert E, LaDu TJ, et al. Anorexia nervosa: treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986;43:177-181
52. Ananth J, Pecknold JC, Van Den Steen N, et al. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog Neuropsychopharmacol Biol Psychiatry 1981;5:257-262
53. Piccinelli M, Pini S, Bellantuono C, et al. Efficacy of drug treatment in obsessive-compulsive disorder: a meta-analytic review. Br J Psychiatry 1995;166:424-443